ClinicalTrials.govpublic full text
Personalized NK Cell Therapy in CBT
accelerated phase chronic myelogenous leukemia, bcr-abl1 positive, acute biphenotypic leukemia, acute lymphoblastic leukemia, acute lymphoblastic leukemia in remission, acute myeloid leukemia with myelodysplasia-related changes, acute myeloid leukemia with variant mll translocations, b acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2); bcr-abl1, chemotherapy-related leukemia, chronic myelomonocytic leukemia, chronic phase chronic myelogenous leukemia, bcr-abl1 positive, high grade b-cell lymphoma with myc and bcl2 or bcl6 rearrangements, iss stage ii plasma cell myeloma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 800851
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.